This company listing is no longer active
Resumen de acción G5Z
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
+ 1 riesgos adicionales
Competidores de Neovasc Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$27.00 |
| 52 Week High | CA$28.00 |
| 52 Week Low | CA$4.50 |
| Beta | 1.98 |
| 1 Month Change | -0.74% |
| 3 Month Change | 45.16% |
| 1 Year Change | 208.57% |
| 3 Year Change | -50.00% |
| 5 Year Change | -96.82% |
| Change since IPO | -99.55% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| G5Z | DE Medical Equipment | Mercado DE | |
|---|---|---|---|
| 7D | 0% | -2.3% | -0.7% |
| 1Y | 208.6% | -3.9% | 4.7% |
Rentabilidad vs. Industria: G5Z exceeded the German Medical Equipment industry which returned -3.4% over the past year.
Rentabilidad vs. Mercado: G5Z exceeded the German Market which returned -7% over the past year.
Volatilidad de los precios
| G5Z volatility | |
|---|---|
| G5Z Average Weekly Movement | 9.0% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.5% |
| 10% least volatile stocks in DE Market | 2.6% |
Precio estable de las acciones: G5Z's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: G5Z's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2000 | 60 | Fred Colen | neovasc.com |
Resumen de fundamentos de Neovasc Inc.
| Estadísticas fundamentales de G5Z | |
|---|---|
| Capitalización bursátil | €74.97m |
| Beneficios(TTM) | -€37.50m |
| Ingresos (TTM) | €3.46m |
21.6x
Ratio precio-ventas (PS)-2.0x
Ratio precio-beneficio (PE)¿Está G5Z sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de G5Z | |
|---|---|
| Ingresos | US$3.81m |
| Coste de los ingresos | US$5.07m |
| Beneficio bruto | -US$1.27m |
| Otros gastos | US$39.93m |
| Beneficios | -US$41.20m |
Últimos beneficios comunicados
Dec 31, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -14.93 |
| Margen bruto | -33.37% |
| Margen de beneficio neto | -1,082.90% |
| Ratio deuda/patrimonio | 79.8% |
¿Cómo se ha desempeñado G5Z a largo plazo?
Ver rendimiento histórico y comparativa